Semnur Pharmaceuticals, Inc. (SMNR, SMNRW)

CIK 1913577 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Semnur Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 10, 202610-Q0001193125-26-342594
Jul 7, 20268-K0001193125-26-297085
Jul 7, 2026424B30001193125-26-297098
Jul 1, 2026424B30001193125-26-291407
Jun 26, 2026SCHEDULE 13D/A0001193125-26-285542
Jun 26, 202640001193125-26-285524
Jun 25, 20268-K0001193125-26-283007
Jun 15, 2026424B30001193125-26-271242
Jun 15, 2026424B30001193125-26-270270
May 18, 2026EFFECT9999999995-26-001684
May 13, 202610-Q0001193125-26-221896
May 12, 2026POS AM0001193125-26-219654
Apr 30, 2026DEF 14A0001193125-26-197655
Apr 30, 2026ARS0001193125-26-197687
Apr 23, 20268-K0001193125-26-173690
Mar 17, 20268-K0001193125-26-110816
Feb 27, 202610-K0001193125-26-082642
Dec 29, 2025EFFECT9999999995-25-003932
Dec 29, 2025424B30001193125-25-335407
Dec 19, 2025S-1/A0001193125-25-326813
Dec 3, 2025S-80001193125-25-306962
Dec 3, 2025S-80001193125-25-306969
Dec 3, 20258-K0001193125-25-306757
Oct 21, 2025S-10001193125-25-245178
Oct 14, 2025SCHEDULE 13D/A0001193125-25-238981